Trial Profile
A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Active and Placebo-Controlled Trial to Evaluate the Analgesic Efficacy and Safety of NTM-001 for the Treatment of Moderately Severe Postoperative Pain Following Bunionectomy
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2023
Price :
$35
*
At a glance
- Drugs Ketorolac (Primary) ; Morphine
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- 25 Oct 2023 Planned End Date changed from 1 Sep 2023 to 1 Jun 2024.
- 25 Oct 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2024.
- 25 Jan 2023 According to Neumentum media release, topline results from the study are expected in second half 2023.